Biopharma Outsourcing to Mexico: BCG-Style Operations Case Interview
Biopharma Outsourcing to Mexico is a medium-difficulty BCG-style operations case interview with 7 interviewer questions and 1 exhibit; candidates finish it in a median 22 minutes. Your first full case is free with an account: run it out loud with an AI interviewer or step by step.
| Case type | Operations |
|---|---|
| Industry | Pharmaceuticals / Biomanufacturing |
| Firm style | BCG |
| Difficulty | Medium |
| Interviewer questions | 7: context, clarifying, structure, math, 2 analysis, synthesis |
| Math questions | 1 |
| Exhibits | 1 |
| Modes | Voice and guided |
| Completed runs | 36 |
| Median time | 22 minutes |
| Source | Adapted from the Wharton consulting club casebook |
Runs, times and ratings are from Road to Offer practice data as of 6 November 2026.
The case
Genome Bio manufactures life-saving biomaterials in the US. COVID increased manufacturing costs, and the client is considering Mexico facilities. Should it outsource supply to Mexico?
The client owns and operates US biomaterial facilities and distributes biomaterials across the US. The objective is to reduce sourcing cost and evaluate an alternate supply chain. Use current annual production volume unless stated otherwise.
The interviewer's first question
Summarize the client situation and the decision we need to support.
Exhibits you will read
- Exhibit A: US vs Mexico Costs
What this case tests
One math step, one exhibit and two analysis questions: this case weighs business judgment above calculation.